Krensavage Asset Management, LLC / VNDA
Krensavage Asset Management, LLC’s Vanda Pharmaceuticals Inc Position
Does Krensavage Asset Management, LLC own Vanda Pharmaceuticals Inc (VNDA)? Yes — 1.18M shares worth $8M (+3.19% of its 13F portfolio) as of Q1 2026.
Position Value
$8M
Q1 2026
Shares
1.18M
% of Portfolio
+3.19%
Quarters Held
13
currently held
Position History VNDA
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.18M | $8M | +3.19% |
| Q4 2025 | 1.18M | $10M | +3.68% |
| Q3 2025 | 1.18M | $6M | +2.51% |
| Q2 2025 | 1.02M | $5M | +2.56% |
| Q1 2025 | 754.4K | $3M | +1.91% |
| Q4 2024 | 378.8K | $2M | +1.07% |
| Q3 2024 | 414.7K | $2M | +1.09% |
| Q2 2024 | 662.2K | $4M | +1.72% |
| Q3 2023 | 360.4K | $2M | +0.57% |
| Q2 2023 | 363.0K | $2M | +0.76% |
| Q1 2023 | 361.6K | $2M | +0.75% |
| Q4 2022 | 345.3K | $3M | +0.79% |
| Q3 2022 | 312.3K | $3M | +0.98% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Krensavage Asset Management, LLC’s full portfolio or all institutional holders of VNDA.